Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07170072 · ClinicalTrials.gov registry record
Shelter HArm Reduction Evaluation
A clinical trial of Overdose and Harm Reduction, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT07170072 is a study of Overdose and Harm Reduction that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 80 participants, below the 260-participant average among 13 other Overdose trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07170072, a study of Overdose and Harm Reduction, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will use mixed methods research to examine overdose and other health-related impacts of harm reduction initiatives in NYC homeless shelters.
Conditions Studied
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2026-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07170072
The ClinicalTrials.gov registry entry for NCT07170072 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 13 other Overdose trials with a reported enrollment target (69% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Overdose appearing as the primary indexed condition, and to 0 interventions.
NCT07170072 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07170072 about?
NCT07170072 is a clinical study titled "Shelter HArm Reduction Evaluation". The proposed study will use mixed methods research to examine overdose and other health-related impacts of harm reduction initiatives in NYC homeless shelters.
What is the current status of trial NCT07170072?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-07-01. Estimated completion is 2026-09-30.
What conditions does trial NCT07170072 study?
This clinical trial studies the following conditions: Overdose, Harm Reduction.
Who is sponsoring clinical trial NCT07170072?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07170072 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk
RECRUITING · NA
-
Emergency Medicine Peer Outreach Worker Engagement for Recovery
RECRUITING
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
ACTIVE NOT RECRUITING · NA
-
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
ACTIVE NOT RECRUITING · NA
-
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.